Importantly, the percentage of positive cells for these markers was significantly higher in MZ-CRC-1 compared to TT cells: OCT3/4 (40.3% vs. 26.5%), SOX2 (96.5% vs. 60.5%), and NANOG (63.8% vs. 1.7%) (Figure 1E). The gene discussed is NANOG; the disease is colorectal carcinoma.